10 February 2026
Latham Advises on Satellos’ US$50 Million Initial US Offering
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Nathan Ajiashvili Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| Adam Gelardi Lead | Latham & Watkins LLP | Partner | Capital Markets | New York |
| KC Sands | Latham & Watkins LLP | Associate | Capital Markets | New York |
| Emma Gilmore | Latham & Watkins LLP | Associate | Capital Markets | New York |
| Molly Mitchell | Latham & Watkins LLP | Associate | Capital Markets | New York |
| Andrea Ramezan-Jackson | Latham & Watkins LLP | Partner | tax | Washington, D.C. |
| Tessa Young | Latham & Watkins LLP | Associate | tax | Washington, D.C. |
| Elizabeth Richards | Latham & Watkins LLP | Partner | FDA regulatory | Washington, D.C. |
| Evan Miller | Latham & Watkins LLP | Associate | FDA regulatory | Washington, D.C. |
| Betty Pang | Latham & Watkins LLP | Partner | healthcare regulatory | Bay Area |
| Eliot Choy | Latham & Watkins LLP | Counsel | intellectual property | New York |
| Arun Mohan | Latham & Watkins LLP | Associate | intellectual property | New York |
| Patrick Chew | Latham & Watkins LLP | Associate | intellectual property | New York |
Stated terms
- Stated value
- USD 50m (US$50 Million)
- What the figure measures
- Issue size
- Client
- Latham & Watkins LLPUnderwriters
- Counterparties
- Satellos Bioscience Inc. (Issuer)